Monique Létourneau
Director/Board Member at Oxfam-Québec
Profile
Monique Létourneau is currently the Director at Oxfam-Québec and a Member at Commerce Équitable Oxfam-québec.
Previously, she worked as a Director at Financial Executives International Canada and Génome Québec, Inc. She was also the Chief Financial Officer at Procyon Biopharma, Inc. and Ambrilia Biopharma, Inc. where she held the position of Chief Financial Officer & EVP-Finance from 2001 to 2009.
Ms. Létourneau is a graduate of HEC Montréal.
Monique Létourneau active positions
| Companies | Position | Start |
|---|---|---|
Oxfam-Québec
 Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty. | Director/Board Member | - |
| Commerce Équitable Oxfam-québec | Corporate Officer/Principal | - |
Former positions of Monique Létourneau
| Companies | Position | End |
|---|---|---|
Financial Executives International Canada
 Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Financial Executives International Canada operates as a professional membership organization. The company is headquartered in Toronto, Canada. | Director/Board Member | 04/06/2014 |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | 19/06/2013 |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Director of Finance/CFO | 29/07/2009 |
Procyon Biopharma, Inc.
 Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | Director of Finance/CFO | 03/03/2006 |
Training of Monique Létourneau
| HEC Montréal | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Procyon Biopharma, Inc.
Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | Commercial Services |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Oxfam-Québec
Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty. | Commercial Services |
Financial Executives International Canada
Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Financial Executives International Canada operates as a professional membership organization. The company is headquartered in Toronto, Canada. | Commercial Services |
| Commerce Équitable Oxfam-québec | |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
- Stock Market
- Insiders
- Monique Létourneau
